Immunovia launches SEK 63 million rights issue with attached warrants
The unit rights issue is subject to shareholder approval at an EGM on Oct. 29, 2026. Each unit includes two shares and one free warrant of series TO 4, intended for trading on Nasdaq Stockholm.